AR220704A1 - Procedimiento para la preparacion de derivados de indanil y tetrahidronaftil octatrieno - Google Patents

Procedimiento para la preparacion de derivados de indanil y tetrahidronaftil octatrieno

Info

Publication number
AR220704A1
AR220704A1 AR272036A AR27203678A AR220704A1 AR 220704 A1 AR220704 A1 AR 220704A1 AR 272036 A AR272036 A AR 272036A AR 27203678 A AR27203678 A AR 27203678A AR 220704 A1 AR220704 A1 AR 220704A1
Authority
AR
Argentina
Prior art keywords
tetrahidronaftil
octatrieno
indanil
derivatives
procedure
Prior art date
Application number
AR272036A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR220704A1 publication Critical patent/AR220704A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/50Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR272036A 1977-05-04 1978-05-04 Procedimiento para la preparacion de derivados de indanil y tetrahidronaftil octatrieno AR220704A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77254A LU77254A1 (cs) 1977-05-04 1977-05-04

Publications (1)

Publication Number Publication Date
AR220704A1 true AR220704A1 (es) 1980-11-28

Family

ID=19728555

Family Applications (1)

Application Number Title Priority Date Filing Date
AR272036A AR220704A1 (es) 1977-05-04 1978-05-04 Procedimiento para la preparacion de derivados de indanil y tetrahidronaftil octatrieno

Country Status (32)

Country Link
US (1) US4193931A (cs)
JP (1) JPS53137940A (cs)
AR (1) AR220704A1 (cs)
AT (1) AT356647B (cs)
AU (1) AU522598B2 (cs)
BE (1) BE866651A (cs)
BR (1) BR7802807A (cs)
CA (1) CA1114830A (cs)
CH (2) CH641755A5 (cs)
CS (1) CS214853B2 (cs)
CU (1) CU21105A (cs)
DE (1) DE2819213A1 (cs)
DK (1) DK155730C (cs)
ES (2) ES469394A1 (cs)
FI (1) FI66587C (cs)
FR (1) FR2390428A1 (cs)
GB (2) GB1600915A (cs)
GR (1) GR74426B (cs)
HU (1) HU183088B (cs)
IE (1) IE46946B1 (cs)
IL (2) IL54590A (cs)
IT (1) IT1096278B (cs)
LU (1) LU77254A1 (cs)
MC (1) MC1193A1 (cs)
MY (1) MY8500250A (cs)
NL (1) NL7804773A (cs)
NO (1) NO148290C (cs)
NZ (1) NZ187114A (cs)
PH (1) PH14216A (cs)
PT (1) PT67988B (cs)
SE (1) SE436644B (cs)
ZA (1) ZA782415B (cs)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216312A (en) * 1978-08-24 1980-08-05 Hoffmann-La Roche Inc. Furyl substituted polyenes
FI67386C (fi) * 1979-06-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sockerderivat
CH651007A5 (de) * 1982-06-24 1985-08-30 Hoffmann La Roche Polyenverbindungen.
DK158947C (da) * 1982-07-06 1991-01-21 Hoffmann La Roche Tetrahydronaphthalin-,benzofuran- og benzothiophenderivater, fremstilling og anvendelse deraf samt rodenticid indeholdende saadanne derivater
US4529600A (en) * 1982-09-09 1985-07-16 Sri International Pentadeuterioretinoids
US4439614A (en) * 1982-09-22 1984-03-27 Sri International 5,6-Methano-5,6-dihydroretinoids
US4464389A (en) * 1982-10-20 1984-08-07 Sri International Esters of retinoic acid and pentaerythritol and monobenzal acetals thereof
US4539154A (en) * 1983-06-15 1985-09-03 Hoffmann-La Roche Inc. Polyene compounds
CH661516A5 (de) * 1983-12-08 1987-07-31 Hoffmann La Roche Phenylnonatetraenoylzuckerderivate.
US4783549A (en) * 1984-09-05 1988-11-08 L'oreal Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
FR2580277B1 (fr) * 1985-04-15 1988-06-10 Oreal Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant
ZW7487A1 (en) * 1986-05-23 1987-12-16 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
AT388728B (de) * 1987-03-17 1989-08-25 Hoffmann La Roche Neue tetrahydronaphthalin- und indanderivate
US5250562A (en) * 1988-02-24 1993-10-05 Hoffmann-La Roche Inc. Stilbene derivatives
US5248696A (en) * 1991-04-18 1993-09-28 World Research Institute For Science And Technology, Inc. Composition and method for treating tumors
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
CA2129773C (en) * 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
FR2719041B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DE69516903T2 (de) * 1994-12-30 2000-10-26 Ligand Pharmaceuticals, Inc. Retinoid trienverbindungen und verfahren
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
DK0873295T3 (da) * 1995-10-06 2003-07-14 Ligand Pharm Inc Dimer-selektive RXR-modulatorer og fremgangsmåder til deres anvendelse
US6112489A (en) * 1995-12-12 2000-09-05 Monotech International, Inc. Monocoque concrete structures
WO1998007716A2 (en) * 1996-08-23 1998-02-26 The Board Of Regents For Oklahoma State University Heteroarotinoids-anticancer agents with receptor specificity and tgase activity
FR2752837B1 (fr) * 1996-09-02 1999-11-12 Cird Galderma Nouveaux composes modulateurs des recepteurs hormonaux, les compositions les comprenant et leur utilisation en therapie
US7098025B1 (en) * 1997-07-25 2006-08-29 Ligand Pharmaceuticals Incorporated Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
US6534545B1 (en) 1997-09-25 2003-03-18 Galderma Research & Development Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
FR2768731B1 (fr) * 1997-09-25 1999-12-10 Cird Galderma Derives insatures en position -4 du 6-tert-butyl-1,1- dimethylindane et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
CA2334545A1 (en) * 1998-06-12 1999-12-16 Ligand Pharmaceuticals Incorporated Treatment of anti-estrogen resistant breast cancer using rxr modulators
BR0013597A (pt) 1999-08-27 2002-07-16 Ligand Pharm Inc Compostos e métodos moduladores de receptor de androgênio
AU6941200A (en) 1999-08-27 2001-03-26 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido(3,2-g)quinoline compounds as androgen receptor modulators
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
PE20010647A1 (es) 1999-09-14 2001-06-23 Lilly Co Eli Moduladores de receptores de retinoide x (rxr) con perfil farmacologico mejorado
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7314953B2 (en) * 2001-03-27 2008-01-01 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US6586460B1 (en) 2001-04-02 2003-07-01 The Board Of Regents For Oklahoma State University Heteroarotinoids containing urea or thiourea linker
CA2486303C (en) * 2002-05-22 2013-04-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
WO2012076842A1 (en) * 2010-12-09 2012-06-14 University Of Durham Synthetic retinoids for control of cell differentiation
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas
JP7416687B2 (ja) * 2017-09-28 2024-01-17 ジョンソン アンド ジョンソン コンシューマー インコーポレイテッド 化粧品組成物及び皮膚の処置方法
CA3107707A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452085A (en) * 1966-02-11 1969-06-24 Carbo Erba Spa Alpha-(5-indanyl)-butyric acid
US3781314A (en) * 1971-07-14 1973-12-25 Hoffmann La Roche Polyene compounds
BE793108A (fr) * 1971-12-22 1973-06-21 Hoffmann La Roche Derives polyeniques
FR2235679B1 (cs) * 1973-07-02 1978-07-21 Takeda Chemical Industries Ltd
CH582668A5 (cs) * 1973-08-10 1976-12-15 Hoffmann La Roche
CH585709A5 (cs) * 1973-08-24 1977-03-15 Hoffmann La Roche
CH592598A5 (cs) * 1973-10-30 1977-10-31 Hexachimie
AR206619A1 (es) * 1974-02-07 1976-08-06 Hexachimie Procedimiento para peparar acidos 5-indanilaceticos
FR2276035A1 (fr) * 1974-06-28 1976-01-23 Lipha Nouveaux derives de l'indane
JPS51125235A (en) * 1974-09-26 1976-11-01 Hoffmann La Roche Preparation of polyene compounds
US4054589A (en) * 1974-09-26 1977-10-18 Hoffmann-La Roche Inc. Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters

Also Published As

Publication number Publication date
GB1600915A (en) 1981-10-21
ES475240A1 (es) 1979-05-16
CH641755A5 (de) 1984-03-15
BE866651A (fr) 1978-11-03
FI781227A (fi) 1978-11-05
DK195378A (da) 1978-11-05
ES469394A1 (es) 1979-02-01
GR74426B (cs) 1984-06-28
FI66587C (fi) 1984-11-12
IT7823003A0 (it) 1978-05-04
IE780864L (en) 1978-11-04
HU183088B (en) 1984-04-28
ATA320478A (de) 1979-10-15
IE46946B1 (en) 1983-11-16
NO148290B (no) 1983-06-06
BR7802807A (pt) 1979-01-02
AU3576278A (en) 1979-11-08
AU522598B2 (en) 1982-06-17
CA1114830A (en) 1981-12-22
NO781586L (no) 1978-11-07
SE436644B (sv) 1985-01-14
IL54590A (en) 1982-02-28
PT67988B (en) 1980-05-05
IT1096278B (it) 1985-08-26
DE2819213A1 (de) 1978-11-16
CH642380A5 (de) 1984-04-13
DK155730B (da) 1989-05-08
GB1600914A (en) 1981-10-21
DE2819213C2 (cs) 1987-09-24
FR2390428B1 (cs) 1983-03-04
IL54590A0 (en) 1978-07-31
NZ187114A (en) 1980-11-14
CS214853B2 (en) 1982-06-25
CU21105A (es) 1981-12-04
FR2390428A1 (fr) 1978-12-08
SE7805136L (sv) 1978-11-05
NL7804773A (nl) 1978-11-07
JPS53137940A (en) 1978-12-01
IL61697A0 (en) 1981-01-30
DK155730C (da) 1989-10-02
US4193931A (en) 1980-03-18
MY8500250A (en) 1985-12-31
NO148290C (no) 1983-09-14
AT356647B (de) 1980-05-12
FI66587B (fi) 1984-07-31
PT67988A (en) 1978-06-01
ZA782415B (en) 1979-04-25
PH14216A (en) 1981-04-02
JPS6332777B2 (cs) 1988-07-01
LU77254A1 (cs) 1979-01-18
MC1193A1 (fr) 1979-02-23

Similar Documents

Publication Publication Date Title
AR220704A1 (es) Procedimiento para la preparacion de derivados de indanil y tetrahidronaftil octatrieno
MX5950E (es) Procedimiento para la preparacion de derivados de la pirrolidin-2-ona
MX5527E (es) Procedimiento para la preparacion de derivados de carboestirilo
AR223815A1 (es) Procedimiento para la preparacion de tetrafluoretano
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
ES489628A0 (es) Procedimiento para la obtencion de derivados de tetrahidro- piridina y piperidina
MX4988E (es) Procedimiento para la preparacion de derivados pirrolidinicos
AR219957A1 (es) Procedimiento para la preparacion de derivados amidicos sustituidos de l y dl-4-hidroxifenilglicina
AR221355A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil y pirrolidinilmetil-benzamidas
AR211887A1 (es) Procedimiento para la preparacion de derivados de endolizina
AR224110A1 (es) Procedimiento para la preparacion de derivados de 5(6)-benzimidazoles
MX5479E (es) Procedimiento para la preparacion de derivados de 1-oxadetiacefalosporinas
ES491142A0 (es) Procedimiento para la preparacion de derivados de fenileti- lamina
MX4796E (es) Procedimiento para la preparacion de derivados de 2-iminotiazolina
AR218296A1 (es) Procedimiento para la preparacion de nuevos derivados de 14-beta-amino-morfina
AR222844A1 (es) Procedimiento para la obtencion de nuevos derivados de n1-glucofuranosil-6-ilo-n3-nitroso-ureas
AR217664A1 (es) Procedimiento para la preparacion de derivados de oleandomicina
MX4884E (es) Procedimiento para la preparacion de derivados de la tienopiridina
MX5066E (es) Procedimiento mejorado para la elaboracion de piridina y 3-metilpiridina
MX5672E (es) Procedimiento para la preparacion de acidos 2-piridil y 2-pirimidil-aminobenzoicos
MX5191E (es) Procedimiento para la preparacion de derivados de n'-fenil-n-metilurea
AR221215A1 (es) Procedimiento para la preparacion de cloroacetanilidas substituidas
AR219780A1 (es) Nuevos derivados de 3,4-metano-pirrolidina y procedimiento para su preparacion
MX5620E (es) Procedimiento mejorado para la preparacion de n-hidroxi-n-fosfonometilglicina
AR224518A1 (es) Procedimiento para la preparacion de derivados de 1-piperidino-ftalazina